- Condition: Cushing's Disease
Intervention: Drug: Pasireotide sub-cutaneous formulation
Sponsors: Novartis; Novartis Pharmaceuticals
Available - verified April 2012 - Condition: Pituitary Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified August 2011 - Condition: Adrenal Insufficiency
Interventions: Procedure: ACTH stimulation test; Procedure: 250 ug ACTH stimulation test; Procedure: 25 ug Cortrosyn stimulation test; Procedure: Insulin tolerance test; Procedure: 1 ug cortrosyn test
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified March 2012 - Conditions: Proteinuria; Idiopathic Membranous Nephropathy
Interventions: Drug: Repository Corticotropin Injection; Drug: Placebo
Sponsors: Questcor Pharmaceuticals, Inc.; Questcor Pharmaceuticals, Inc.
Recruiting - verified January 2012 - Condition: Functional Dyspepsia
Intervention: Drug: Acthrel
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City
Not yet recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: ketoconazole; Drug: inert powder
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center
Recruiting - verified March 2012 - Condition: West Syndrome
Intervention: Drug: adrenocorticotropin hormone
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital; Thrasher Research Fund
Not yet recruiting - verified June 2011 - Conditions: Brain Edema; Brain Tumor
Intervention: Drug: XERECEPT (corticorelin acetate injection)
Sponsors: Celtic Pharma Development Services; Celtic Pharma Development Services
Recruiting - verified June 2011 - Condition: Cushing Disease
Intervention: Drug: LCI699
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Alcohol-Related Disorders; Alcohol Dependence; Alcoholism; Anxiety Disorder
Interventions: Drug: Pexacerfont; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified August 2011 - Condition: Alcohol Dependence
Interventions: Drug: GSK561679; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified November 2011 - Conditions: Breast Cancer; Fatigue
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Multiple Sclerosis
Interventions: Drug: ACTH; Drug: Methylprednisolone
Sponsors: University of Southern California; University of Southern California; Questcor Pharmaceuticals, Inc.
Recruiting - verified July 2011 - Condition: Stress Disorders, Post-Traumatic
Interventions: Drug: GSK561679; Drug: Placebo
Sponsors: Emory University; Emory University; Mount Sinai School of Medicine
Recruiting - verified October 2011 - Condition: Polycystic Ovary Syndrome
Interventions: Radiation: 3-D Ultrasound; Drug: hCG with and without FSH; Drug: Adrenocorticotropin (ACTH) infusion; Drug: Diazoxide and hCG
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified August 2011 - Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: ACTH
Sponsors: Mayo Clinic; Mayo Clinic; Questcor Pharmaceuticals, Inc.
Recruiting - verified May 2012
 |
Adrenocorticotropic Hormone Clinical Trials |
